Ginger Clark

Ginger Clark, M.D., M.S.

Program Director & Associate Professor

Department: MD-GASTROENTERLOGY-LIVER
Business Email: clarkvc@medicine.ufl.edu

Accomplishments

Exemplary Teacher Award
2019 · College of Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Gastroenterology
  • Transplant Hepatology

Publications

2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency
Gut. [DOI] 10.1136/gutjnl-2020-323729. [PMID] 33632708.
2019
Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD.
Journal of critical care. 54:212-219 [DOI] 10.1016/j.jcrc.2019.08.027. [PMID] 31614323.
2019
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 67(2):303-311 [DOI] 10.1136/jim-2018-000864. [PMID] 30309884.
2018
Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Journal of hepatology. 69(6):1357-1364 [DOI] 10.1016/j.jhep.2018.08.005. [PMID] 30138687.
2018
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 16(4):558-566.e2 [DOI] 10.1016/j.cgh.2017.12.001. [PMID] 29223443.
2017
Evaluating the Efficacy of a Registry linked to a Consent to Re-Contact Program and Communication Strategies for Recruiting and Enrolling Participants into Clinical Trials.
Contemporary clinical trials communications. 8:62-66 [DOI] 10.1016/j.conctc.2017.08.005. [PMID] 29503877.
2017
Liver Transplantation in Alpha-1 Antitrypsin Deficiency
Clinics in Liver Disease. 21(2):355+-365 [DOI] 10.1016/j.cld.2016.12.008.
2017
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
The lancet. Gastroenterology & hepatology. 2(10):716-726 [DOI] 10.1016/S2468-1253(17)30246-7. [PMID] 28818518.
2014
Cyproheptadine-Induced Acute Liver Failure.
ACG case reports journal. 1(4):212-213 [PMID] 25580444.
View on: PubMed
2013
An Unusual Case of Gastrointestinal Bleeding
American Journal of Gastroenterology. 108(1)
2013
CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
Liver international : official journal of the International Association for the Study of the Liver. 33(1):72-8 [DOI] 10.1111/liv.12013. [PMID] 23107586.
2013
Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.
Digestive diseases and sciences. 58(5):1403-9 [DOI] 10.1007/s10620-012-2521-9. [PMID] 23306846.
2013
Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology. 43(7):757-64 [DOI] 10.1111/hepr.12019. [PMID] 23193965.
2013
New therapeutic strategies in HCV: second-generation protease inhibitors.
Liver international : official journal of the International Association for the Study of the Liver. 33 Suppl 1:80-4 [DOI] 10.1111/liv.12061. [PMID] 23286850.
2013
The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma.
Alimentary pharmacology & therapeutics. 37(1):91-7 [DOI] 10.1111/apt.12098. [PMID] 23094860.
2013
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.
Oncology reports. 29(4):1259-67 [DOI] 10.3892/or.2013.2290. [PMID] 23426976.
2012
Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation.
American journal of clinical oncology. 35(4):345-50 [DOI] 10.1097/COC.0b013e31821631f6. [PMID] 21552101.
2012
Incidentally Discovered Hcc (Ihcc) in Explant Liver- Clinical and Histopathologic Features and Outcome
Higher Education Policy. 56:476A-477A
2012
Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiency.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 10(11):1278-83 [DOI] 10.1016/j.cgh.2012.07.007. [PMID] 22835581.
2012
The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver. 32 Suppl 1:103-7 [DOI] 10.1111/j.1478-3231.2011.02711.x. [PMID] 22212579.
2011
A Sustained Viral Response Dramatically Improves Survival in Patients With Hepatitis C Infection After Liver Transplant
. 54
2011
Alt Abnormalities in Adults With Alpha-1 Antitrypsin Deficiency
. 54
2011
Antiviral Effect of Sorafenib in Hcv Related Hepatocellular Carcinoma
Higher Education Policy. 54
2011
Klatskin Tumor- Clinical Outcome and Prognostic Factors
Higher Education Policy. 54
2011
Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.
Hepatology international. 5(3):808-13 [DOI] 10.1007/s12072-011-9260-4. [PMID] 21484124.
2011
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
Alimentary pharmacology & therapeutics. 33(2):235-42 [DOI] 10.1111/j.1365-2036.2010.04512.x. [PMID] 21083674.
2011
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma.
Alimentary pharmacology & therapeutics. 34(2):205-13 [DOI] 10.1111/j.1365-2036.2011.04697.x. [PMID] 21605146.
2010
The Impact of Preservation Injury On Accelerated Hepatitis C Recurrence After Liver Transplantation
Higher Education Policy. 52
2010
The Impact of Transarterial Therapy in Recurrent Hepatocellular Carcinoma After Liver Transplant
Higher Education Policy. 52
2010
The Impact of Transarterial Therapy in Recurrent Hepatocellular Carcinoma After Liver Transplant
Higher Education Policy. 52
2010
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
Digestive diseases and sciences. 55(1):196-203 [DOI] 10.1007/s10620-009-0981-3. [PMID] 19798576.
2010
Treatment of chronic hepatitis C in patients with Crohn’s disease.
Gastroenterology & hepatology. 6(8):527-8 [PMID] 20978558.
View on: PubMed
2009
Fenofibrate Improves Liver Biochemistries in Primary Biliary Cirrhosis
Higher Education Policy. 50
2009
Novel interferons for treatment of hepatitis C virus.
Clinics in liver disease. 13(3):351-63 [DOI] 10.1016/j.cld.2009.05.004. [PMID] 19628153.
2009
The natural history of hepatitis C cirrhosis after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 15(9):1063-71 [DOI] 10.1002/lt.21784. [PMID] 19718647.
2008
The Natural History of Hcv-Related Cirrhosis After Liver Transplantation
. 48 [DOI] 10.1016/S0168-8278(08)60003-3.
2007
What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?
Nature clinical practice. Gastroenterology & hepatology. 4(4):188-9 [PMID] 17290236.
View on: PubMed

Grants

May 2020 ACTIVE
Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH
Role: Co-Investigator
Funding: NATL INST OF HLTH NIDDK
Dec 2015 – Dec 2018
a 12 week double blind randomized placebo-controlled
Role: Principal Investigator
Funding: CYMABAY THERAPEUTICS
Mar 2015 – Mar 2018
LAL-CSS01 A STUDY TO IDENTIFY THE FREQUENCY OF LYSOSOMAL ACID LIPASE DEFICIENCY IN AT-RISK PATIENT POPULATIONS
Role: Principal Investigator
Funding: SYNAGEVA BIOPHARMA
Jan 2013 – Jan 2016
00087226 Clark, V GENFIT GFT505-212-7 'A Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients with (NASH) A Multicentre, Rand DB, Placebo-Controlled Study, with an Adaptive Design
Role: Principal Investigator
Funding: PREMIER RESEARCH INTERNATIONAL
Jul 2007 – Aug 2016
Clinical and Translational Science Institute
Role: Project Manager
Funding: UF RESEARCH FOU

Teaching Profile

Courses Taught
2019-2020
BMS6634 GI and Hepatology
2016-2018
MDT7200 Elect Top/Medicine
2018
MDC6001 Intro Clin Practice
2018
PAS5160 Gastroenterology

Contact Details

Emails: